Adocia S.A.

Adocia S.A.

ADOCY - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$233.72M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Adocia S.A.Adocia S.A.-5.8-547%--1.8

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$233.72 Million
Enterprise Value$232.38 Million
Earnings per Share$-0.81
Beta0.86
Outstanding Shares19,807,000

Return

Return on Equity546.67%ROE
Return on Assets-117.00%
Return on Invested Capital-607.78%

Valuation & Multiples

P/E Ratio-5.77P/E Ratio
PEG-939.35PEG
Price to Sales-Price to Sales
Price to Book Ratio-11.8Price to Book Ratio
Enterprise Value to Revenue24.89
Enterprise Value to EBIT-17.89
Enterprise Value to Net Income-10
Total Debt to Enterprise0.04
Debt to Equity-1.84Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
September 24, 2026
EPS
-$0.50
Est. -$0.50
Revenue
$1.52 M
Est. $48,897

Next Earnings Call

Expected Date
March 3, 2027
EPS Estimate
-$0.53
Consensus analyst estimate
Revenue Estimate
-
Consensus analyst estimate

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Adocia S.A.

80 employees
CEO: Olivier Soula

Adocia S.A. is a clinical-stage biotechnology firm that specializes in developing enhanced formulations of existing therapeutic proteins and peptides, primarily targeting diabetes and other metabolic disorders. The company leverages its ...